Answers are grounded in this paper and cite their sources.
Platelet-activating factor stimulates phosphatidylinositol turnover in human platelets as indicated by [32P]phosphatidate accumulation in platelets pre-labelled with [32P]Pi, and by [3H]phosphatidate accumulation and [3H]phosphatidylinositol loss in platelets pre-labelled with [3H]arachidonate. These effects of platelet-activating factor are direct and are independent of the production and/or release of endogenous platelet agonists such as ADP, 5-hydroxytryptamine and thromboxane A2.
No takes yet. Share an insight, caveat, or question.
MacIntyre et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: